Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |